Alx Oncology Holdings Inc (NASDAQ: ALXO) is -89.86% lower on its value in year-to-date trading and has touched a low of $1.42 and a high of $17.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ALXO stock was last observed hovering at around $1.56 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $1.51, the stock is -12.69% and -27.85% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.75 million and changing -3.21% at the moment leaves the stock -83.90% off its SMA200. ALXO registered -82.24% loss for a year compared to 6-month loss of -90.41%. The firm has a 50-day simple moving average (SMA 50) of $2.093 and a 200-day simple moving average (SMA200) of $9.379475.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -29.44% gain in the last 1 month and extending the period to 3 months gives it a -75.45%, and is 4.86% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.84% over the week and 7.51% over the month.
Alx Oncology Holdings Inc (ALXO) has around 72 employees, a market worth around $79.53M and $0.00M in sales. Distance from 52-week low is 6.34% and -91.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-97.94%).
The EPS is expected to grow by 18.63% this year
165.0 institutions hold shares in Alx Oncology Holdings Inc (ALXO), with institutional investors hold 109.35% of the company’s shares. The shares outstanding are 49.95M, and float is at 30.21M with Short Float at 30.85%. Institutions hold 107.25% of the Float.
The top institutional shareholder in the company is VENBIO PARTNERS LLC with over 9.7 million shares valued at $58.49 million. The investor’s holdings represent 19.3531 of the ALXO Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 7.81 million shares valued at $47.12 million to account for 15.5923 of the shares outstanding. The other top investors are VIVO CAPITAL, LLC which holds 4.22 million shares representing 8.4198 and valued at over $25.45 million, while REDMILE GROUP, LLC holds 8.0535 of the shares totaling 4.04 million with a market value of $24.34 million.
Alx Oncology Holdings Inc (ALXO) Insider Activity
The most recent transaction is an insider sale by Pinto Shelly, the company’s SVP, FINANCE AND CAO. SEC filings show that Pinto Shelly sold 564 shares of the company’s common stock on Aug 14 ’24 at a price of $2.58 per share for a total of $1455.0. Following the sale, the insider now owns 91549.0 shares.
Alx Oncology Holdings Inc disclosed in a document filed with the SEC on Aug 14 ’24 that Randolph Sophia (CHIEF MEDICAL OFFICER) sold a total of 1,365 shares of the company’s common stock. The trade occurred on Aug 14 ’24 and was made at $2.58 per share for $3522.0. Following the transaction, the insider now directly holds 0.33 million shares of the ALXO stock.
Still, SEC filings show that on Aug 14 ’24, Pons Jaume (PRESIDENT & CSO) disposed off 1,937 shares at an average price of $2.58 for $4997.0. The insider now directly holds 591,510 shares of Alx Oncology Holdings Inc (ALXO).
